Paper29686151
Analysis of Clinical Drug-Drug Interaction Data To Predict Magnitudes of Uncharacterized Interactions between Antiretroviral Drugs and Comedications.
Stader F and 6 others. Antimicrob Agents Chemother, 2018. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. Analysis of Clinical Drug-Drug Interaction Data To Predict Magnitudes of Uncharacterized Interactions between Antiretroviral Drugs and Comedications. Papers, record 29686151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29686151
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Analysis of Clinical Drug-Drug Interaction Data To Predict Magnitudes of Uncharacterized Interactions between Antiretroviral Drugs and Comedications.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Retroviral Agents | Major topic |
| Cytochrome P-450 CYP3A Inhibitors | Major topic |
| HIV Infections | Major topic |
| Cytochrome P-450 CYP3A | |
| Drug Interactions | |
| Humans | |
| Monte Carlo Method |
Source PubMed
References56
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23568224 | Investigation of the effects of ketoconazole on the pharmacokinetics of macitentan, a novel dual endothelin receptor antagonist, in healthy subjects. | Clin Pharmacokinet | 2013 | https://conductscience.org/library/papers/23568224 | PubMed |
| 2 | 20380564 | Recognition of risk for clinically significant drug interactions among HIV-infected patients receiving antiretroviral therapy. | Clin Infect Dis | 2010 | https://conductscience.org/library/papers/20380564 | PubMed |
| 3 | 17896893 | Prevalence and risk factors for clinically significant drug interactions with antiretroviral therapy. | Pharmacotherapy | 2007 | https://conductscience.org/library/papers/17896893 | PubMed |
| 4 | 3802710 | Cimetidine and ranitidine increase midazolam bioavailability. | Clin Pharmacol Ther | 1987 | https://conductscience.org/library/papers/3802710 | PubMed |
| 5 | 8181191 | Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole. | Clin Pharmacol Ther | 1994 | https://conductscience.org/library/papers/8181191 | PubMed |
| 6 | 8623953 | The effects of the systemic antimycotics, itraconazole and fluconazole, on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam. | Anesth Analg | 1996 | https://conductscience.org/library/papers/8623953 | PubMed |
| 7 | 2933205 | Effect of single doses of cimetidine and ranitidine on the steady-state plasma levels of midazolam. | Clin Pharmacol Ther | 1985 | https://conductscience.org/library/papers/2933205 | PubMed |
| 8 | 16639344 | Lopinavir/ritonavir induces the hepatic activity of cytochrome P450 enzymes CYP2C9, CYP2C19, and CYP1A2 but inhibits the hepatic and intestinal activity of CYP3A as measured by a phenotyping drug cocktail in healthy volunteers. | J Acquir Immune Defic Syndr | 2006 | https://conductscience.org/library/papers/16639344 | PubMed |
| 9 | 14551182 | Pharmacokinetic and pharmacodynamic interactions of oral midazolam with ketoconazole, fluoxetine, fluvoxamine, and nefazodone. | J Clin Pharmacol | 2003 | https://conductscience.org/library/papers/14551182 | PubMed |
| 10 | 16580903 | Comparison of midazolam and simvastatin as cytochrome P450 3A probes. | Clin Pharmacol Ther | 2006 | https://conductscience.org/library/papers/16580903 | PubMed |
| 11 | 10320951 | Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection. | Clin Pharmacokinet | 1999 | https://conductscience.org/library/papers/10320951 | PubMed |
| 12 | 15980690 | Effect of efavirenz on the pharmacokinetics of simvastatin, atorvastatin, and pravastatin: results of AIDS Clinical Trials Group 5108 Study. | J Acquir Immune Defic Syndr | 2005 | https://conductscience.org/library/papers/15980690 | PubMed |
| 13 | 25006781 | Application of a Physiologically Based Pharmacokinetic Model to Predict OATP1B1-Related Variability in Pharmacodynamics of Rosuvastatin. | CPT Pharmacometrics Syst Pharmacol | 2014 | https://conductscience.org/library/papers/25006781 | PubMed |
| 14 | 9542477 | Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole. | Clin Pharmacol Ther | 1998 | https://conductscience.org/library/papers/9542477 | PubMed |
| 15 | 10579473 | Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: effect of ketoconazole. | Clin Pharmacol Ther | 1999 | https://conductscience.org/library/papers/10579473 | PubMed |
| 16 | 15784650 | CYP3A4 substrate selection and substitution in the prediction of potential drug-drug interactions. | J Pharmacol Exp Ther | 2005 | https://conductscience.org/library/papers/15784650 | PubMed |
| 17 | 9626922 | Effect of itraconazole on the pharmacokinetics and pharmacodynamics of zolpidem. | Eur J Clin Pharmacol | 1998 | https://conductscience.org/library/papers/9626922 | PubMed |
| 18 | 20516560 | Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study. | Antivir Ther | 2010 | https://conductscience.org/library/papers/20516560 | PubMed |
| 19 | 27226953 | Recent Advances in Development and Application of Physiologically-Based Pharmacokinetic (PBPK) Models: a Transition from Academic Curiosity to Regulatory Acceptance. | Curr Pharmacol Rep | 2016 | https://conductscience.org/library/papers/27226953 | PubMed |
| 20 | 16390352 | Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine pharmacokinetics. | Br J Clin Pharmacol | 2006 | https://conductscience.org/library/papers/16390352 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42076117 | Physiologically Based Pharmacokinetic Modeling to Assess Antiretroviral-BTK Inhibitor Interactions and Provide Recommendations for Co-Administration Regimens. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42076117 | PubMed |
| 41308787 | Biowaiver monograph for immediate-release solid oral dosage forms: Amlodipine besylate. | J Pharm Sci | 2026 | https://conductscience.org/library/papers/41308787 | PubMed |
| 37496693 | Antiviral Treatment in Older Chinese Patient with SARS-CoV-2 and Influenza A Virus Co-Infection: A Case Series. | Infect Drug Resist | 2023 | https://conductscience.org/library/papers/37496693 | PubMed |
| 36253637 | Management of potential drug-drug interactions with nirmatrelvir-ritonavir and oral anticoagulants: a case series. | J Thromb Thrombolysis | 2022 | https://conductscience.org/library/papers/36253637 | PubMed |
| 33731842 | Potential drug-drug interactions of antiretrovirals and antimicrobials detected by three databases. | Sci Rep | 2021 | https://conductscience.org/library/papers/33731842 | PubMed |
| 33626178 | Physiologically-Based Pharmacokinetic Modeling to Support the Clinical Management of Drug-Drug Interactions With Bictegravir. | Clin Pharmacol Ther | 2021 | https://conductscience.org/library/papers/33626178 | PubMed |
| 33452585 | Population pharmacokinetic modelling to quantify the magnitude of drug-drug interactions between amlodipine and antiretroviral drugs. | Eur J Clin Pharmacol | 2021 | https://conductscience.org/library/papers/33452585 | PubMed |
| 32011104 | The challenge of HIV treatment in an era of polypharmacy. | J Int AIDS Soc | 2020 | https://conductscience.org/library/papers/32011104 | PubMed |
| 31583609 | Physiologically Based Pharmacokinetic Modelling to Identify Pharmacokinetic Parameters Driving Drug Exposure Changes in the Elderly. | Clin Pharmacokinet | 2020 | https://conductscience.org/library/papers/31583609 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CYP3A4 | 1576 | PubTator's text mining | https://conductscience.org/library/genes/1576 | NCBI Gene |
| CYP3A43 | 64816 | PubTator's text mining | https://conductscience.org/library/genes/64816 | NCBI Gene |
| CYP3A5 | 1577 | PubTator's text mining | https://conductscience.org/library/genes/1577 | NCBI Gene |
| CYP3A7 | 1551 | PubTator's text mining | https://conductscience.org/library/genes/1551 | NCBI Gene |
| UGT1A4 | 54657 | PubTator's text mining | https://conductscience.org/library/genes/54657 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29686151
GET https://conductscience.org/api/papers/v1/29686151/references?page=2